Page results
-
Information on the different ways you can travel to University College London Hospitals (UCLH) if you don’t qualify for patient transport. It also includes advice on financial support that may be available to you.
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
This page is for patients who are about to start a course of radiotherapy to the prostate/prostate bed.
-
This information has been written for patients who are having total body irradiation (TBI) for a haematological cancer.
-
The musculoskeletal (MSK) outpatient therapy service at University College Hospital provides assessment and treatment of patients for a variety of specialities including orthopaedic, rheumatology, hand therapy, women’s health, orthotic, podiatry and spinal non-operative and operative patients with musculoskeletal dysfunction.
-
This page explains what extravasation is, and outlines the steps we take when it occurs.
-
The sleep service at UCH is run within the department of Thoracic Medicine. We have particular expertise in the diagnosis and management of ventilatory disorders during sleep, including obstructive sleep apnoea syndrome, sleep disordered breathing and assessment of respiratory failure.
-
A drop-in service providing support, practical advice and information.
-
Out-patient IV antibiotic service
-
This page has been written for patients who have been recommended hormone therapy for prostate cancer. It explains what the treatment involves, describes side-effects you may experience, and how best to cope with them.
File results
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust